Telomere length dynamics do not predict subclinical atherosclerosis progression over a six-year period

Vicente Andrés1,2, Juan M Fernández-Alvira3, Beatriz Dorado3,4

  • 1Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, Madrid, 28029, Spain. vandres@cnic.es.

Geroscience
|May 27, 2026
PubMed

Insights

Changes in leukocyte telomere length (LTL) do not predict subclinical atherosclerosis (SA) progression in healthy middle-aged adults. This longitudinal study found no significant association between LTL dynamics and SA progression over six years.

Area of Science:

  • Cardiovascular Disease Research
  • Biomarker Discovery
  • Aging and Longevity Studies

Background:

  • Subclinical atherosclerosis (SA) progression is linked to mortality, necessitating reliable biomarkers.
  • Leukocyte telomere length (LTL) attrition is associated with cardiovascular disease, but its predictive value for SA progression is unclear.

Purpose of the Study:

  • To investigate whether accelerated LTL attrition predicts SA progression over a 6-year period.
  • To evaluate LTL dynamics as a potential early biomarker for subclinical atherosclerosis progression in healthy middle-aged individuals.

Main Methods:

  • Longitudinal study of 1068 healthy middle-aged participants from the Progression of Early Subclinical Atherosclerosis (PESA) study.
  • Leukocyte telomere length (LTL) measured using high-throughput quantitative fluorescence in-situ hybridization at baseline and after 6 years.
  • Subclinical atherosclerosis (SA) assessed via 3D vascular ultrasound of carotid and femoral arteries; statistical analyses employed linear and logistic regression.

Main Results:

  • No significant association was found between changes in LTL and changes in plaque volume over 6 years.
  • LTL dynamics did not predict the odds of SA progression over the 6-year study period.
  • Analysis of short telomere load changes yielded similar null results.

Conclusions:

  • Leukocyte telomere length (LTL) dynamics demonstrate limited utility as an early predictive biomarker for subclinical atherosclerosis (SA) progression.
  • Further research may be needed to identify reliable and cost-effective biomarkers for monitoring SA progression.

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replication in Eukaryotes02:31

Replication in Eukaryotes

Overview